Eyeworld Daily News

2019 ASCRS•ASOA San Diego Daily Saturday

EyeWorld Today is the official daily of the ASCRS Symposium & Congress. Each issue provides comprehensive coverage editorial coverage of meeting presentations, events, and breaking news

Issue link: https://daily.eyeworld.org/i/1116412

Contents of this Issue

Navigation

Page 23 of 98

ASCRS NEWS point, Juvene is being researched at two international sites and has been implanted in 44 eyes. Patients will be followed for 12 months. Elizabeth Yeu, MD, Nor- folk, Virginia, introduced the topic of postoperative corneal adjust- ability, providing data about the myopia epidemic and the ubiqui- tous state of presbyopia. Follow- ing, representatives from several companies discussed technologies that address these issues at the corneal plane. William Wiley, MD, Cleve- land, said when it comes to presbyopia correction, there are a lot of pieces to the puzzle, and he doesn't think there will be one solution to solve that puzzle. Small aperture optics have a place in presbyopia correction, Dr. Wiley said, discussing the use of inlays in his practice, especially the KAMRA inlay (CorneaGen). Dr. Wiley said he sees an opportunity in presbyopic patients who come in for LASIK; he will do a simultaneous inlay in their nondominant eye. Haze, as seen in some cases of the now recalled Raindrop inlay (ReVision Optics), is not a concern with KAMRA, Dr. Wiley said, if it's implanted at a proper depth in the cornea. Aylin Kilic, MD, Istanbul, Turkey, presented on the use of allogenic inlays (Allotex) placed under a LASIK-like flap. This product is currently under re- view at seven European sites and will include 121 eyes. Dr. Kilic said because allogenic inlays are human tissue, they have seen good remodeling of the cornea without haze. Raj Rajpal, MD, McLean, Virginia, spoke on photorefractive intrastromal crosslinking (PiXL, Avedro) with the company's Mosa- ic device (not available in the U.S.). This noninvasive, 30-minute pro- cedure provides a customized light pattern for selective stiffening and can be used to treat presbyopia and also low amounts of myopia and hyperopia. Finally, John Vukich, MD, Madison, Wisconsin, presented on the LIRIC platform (laser-in- duced refractive index change, Clerio Vision). This technology, which uses low-pulse femtosecond laser energy, he said, is applicable to the cornea, IOL, and contact lenses. It involves taking a uniform shape and changing the refractive index so that it bends the light in a different way. With the cornea, for example, the shape remains unchanged, but it's the refractive index in a thin layer of the cornea that affects the refractive correc- tion, Dr. Vukich said. Editors' note: The speakers have finan- cial interests related to their comments. NexTech 21 continued from page 20 Maximize Efficiency with the Most Intuitive Ophthalmology EMR Nextech.com/Ophthalmology (800) 868-3694 NEW Accurate Coding IMPROVED Knowledge Base NEW Assisted Compliance IntelleChartPRO IntelleChartPRO DISCOVER New & Enhanced Features at ASCRS Booth #1833

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld Daily News - 2019 ASCRS•ASOA San Diego Daily Saturday